If someone in the pharmaceutical industry came upon a cheaper, non-addictive, and more effective painkiller, would he kill for it? Washington D.C. private detective Robert "Don't call me Bobby" Brixton, along with his mentors, attorneys Mac and Annabel Smith, discover that the answer is a resounding "Yes," as they try to help Jayla King, a medical researcher at a small D.C. pharmaceutical firm, carry on the work of her father. His experiments in the...

The blistering inside story of a startup that made millions pushing opioids-until its cutthroat tactics were exposed and its executives put behind bars John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It wasthe 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention and...

The Sackler name adorns the walls of many storied institutions—Harvard, the Metropolitan Museum of Art, Oxford, the Louvre. They are one of the richest families in the world, known for their lavish donations to the arts and the sciences. The source of the family fortune was vague, however, until it emerged that the Sacklers were responsible for making and marketing a blockbuster painkiller that was the catalyst for the opioid crisis. Empire...

In New York Times bestselling author Joseph Finder's new thriller, private investigator Nick Heller is hired to infiltrate a powerful family whose wealth and reputation hide something far more sinister-- Nick Heller is at the top of his game when he receives some devastating news: his old army buddy Sean has died of an overdose. Sean, who once saved Nick's life, got addicted to opioids after returning home wounded from war. Then, at Sean's funeral,...

The United States has stared down many threats with President Jack Ryan at the helm, but what if he’s not there when we need him? That’s the question facing a nation in the most shocking entry in Tom Clancy's #1 New York Times bestselling series. A shadowy billionaire uses his fortune to further his corrupt ambitions. Along the way, he’s toppled democratically elected governments and exacerbated divisions within stable nations. The competitors...

New York Times bestselling author Joan Johnston has captivated millions of readers with her sprawling, sensuous novels about the two opposing dynasties of Bitter Creek, Texas -- the Blackthornes and the Creeds. Now in her highly anticipated hardcover debut, Johnston tells an impassioned story of love and danger, ambition and family, that features the popular character Luke Creed, a young man who has turned his back on his family's ranch to pursue...

When the application for a new sedative called Kevadon--commonly known as thalidomide--landed on Frances Kelsey's desk at the FDA in 1960, it seemed destined to sail through the review process. The drug, billed as entirely risk-free, was already being sold in forty-six countries. But when Kelsey learned that the drug caused terrible birth defects, she and a team of dedicated doctors, parents, and journalists fought Merrell, the drug's American manufacturer,...

For many years Zeke Caldwell has been concocting home remedies made from natural ingredients. One of his remedies proved so effective that he patented it. Now he suspects a drug company has stolen his formula. When Zeke asks David Cobb to help fight the drug company, David knows the suit is beyond his expertise. But his sister-in-law, Katelyn Martin-Cobb, is a rising star attorney in a prestigious law firm. Could she help? Would she even consider...

Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry.